SciELO - Scientific Electronic Library Online

 
vol.36 issue4Female authorship in the Revista Peruana de Medicina Experimental y Salud Publica: analysis for the period 1997-2017External user satisfaction with healthcare at facilities of the Ministry of Health of Peru and its associated factors author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Peruana de Medicina Experimental y Salud Publica

Print version ISSN 1726-4634

Abstract

VASQUEZ-URIARTE, Karina; NINATANTA ORTIZ, Juana Aurelia; ROMANI, Franco  and  ROQUE-HENRIQUEZ, Joel Christian. Coverage and factors associated with measles vaccination in children aged 12-59 months in Peru: estimate based on the 2017 demographic and family health survey. Rev. perú. med. exp. salud publica [online]. 2019, vol.36, n.4, pp.610-619. ISSN 1726-4634.  http://dx.doi.org/10.17843/rpmesp.2019.360.4456.

Objectives. To estimate coverage and determine factors associated with measles vaccination in Peru. Materials and Methods. We conducted a secondary source study using the 2017 Demographic and Family Health Survey (ENDES). The reporting unit was a woman of childbearing age, 15 to 49 years; the unit of analysis was a child, 12 to 59 months (for the first dose), or a child, 18 to 59 months (for the booster dose) who had vaccination information. Coverage data were obtained from the vaccination card. Results. According to the vaccination card, coverage for the first dose was 70.2% (95% CI: 68.8-71.6); for the booster dose, 52% (95% CI: 50.5-53.6). Children aged 24-35 months were more likely to be vaccinated for the first dose (OR 1.59, 95% CI: 1.28-1.97) and booster dose (OR 2.04, 95% CI: 1.62-2.56), compared with children aged 12-23 months and 18-23 months respectively. Children with growth and development check-ups performed in the private sector were less likely to be vaccinated for the first dose (OR 0.30, 95% CI: 0.21-0.43) and booster dose (OR 0.26, 95% CI: 0.17-0.40), compared to those being monitored in the public sector. Conclusions. According to ENDES 2017, Peru and none of its regions achieved 95.0% coverage for the first and booster doses. Growth and development monitoring in public sector facilities is associated with measles vaccination in terms of first and booster doses.

Keywords : Measles; Vaccination; Vaccination Coverage; Peru.

        · abstract in Spanish     · text in Spanish     · English ( pdf ) | Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License